Kunal Chaudhary, MD

Kunal Chaudhary, MD

Medicine

Section Chief, Division of Nephrology, HSTVH
Courtesy Faculty

Division

Nephrology

Academic Information

Section Chief, Division of Nephrology, HSTVH
Courtesy Faculty

Research Interests

  • Dialysis
  • Hypertension (high blood pressure)
  • Kidney (renal) disease
  • Kidney stones

Areas of Expertise

  • Dialysis
  • Hypertension (high blood pressure)
  • Kidney (renal) disease
  • Kidney stones

Education & Training

Medical School

Rajendra Medical College

Internship

Internal Medicine

University of Tennessee Medical Center-Knoxville

Residency

Internal Medicine

University of Tennessee Medical Center-Knoxville
University of Tennessee Medical Center-Knoxville

Fellowship

Nephrology

University of Tennessee Health Science Center-Memphis

Board Certification

American Board of Internal Medicine/Nephrology

Awards & Honors

Memberships

  • International Society of Peritoneal Dialysis
  • American Society of Nephrology
  • American Society of Hypertension

Councils and Committees

  • American Society of Nephrology: Fellow and Council Member
  • American Society of Hypertension: Council Member for Midwest Chapter

Publications

  • Lishmanov A, Dorairajan S, Pak Youngju, Chaudhary Kunal, Chockalingam A(2012) . Serum intact parathormone as a cardiovascular risk factor for patients with moderate CKD. Int Journal Urol Nephrol  ;44(2):541-7.
  • Yerram Preethi, Karuparthi PR, Chaudhary Kunal.(2012) Pathogenesis and management of renovascular disease and ischemic nephropathy Minerva Urol e Nefrol 64(1): 63-72.
  • Ramanath Vinayak, Nistala Ravi, Chaudhary Kunal.(2012) Update on the role of Rituximab in kidney diseases and transplant. Expert Opin Biol Ther.  12(2):223-33.
  • Ramanath Vinayak, Diptesh Gupta, Juhi Jain, Chaudhary Kunal and Nistala Ravi (2012).  Anemia and chronic kidney disease: making sense of recent trials. Rev Recent Clin Trials. 2012 Aug 1;7(3):187-96
  • Bichu Prasad and Chaudhary Kunal. (2012) Non-Infectious Complications of Immunosuppressant Medications in Renal Transplant Patients Current Clin Pharmacology, 7(4): 254-62.
  • Chaudhary Kunal.  Current perspective on peritoneal dialysis. (2012) (Editorial). Journal of Nephrology and Therapeutics. 2:e107. doi:10.4172/2161-0959.1000e107
  • Ariyamuthu V, Balla Sudarshan and Chaudhary Kunal (2012).  Ischemic Heart disease in patients undergoing dialysis: Hospital Practice 2012 Oct;40(4):33-9. doi: 10.3810/hp. 2012.10.1001.
  • Chaudhary Kunal, Malhotra Kunal, Sowers James, and Aroor A.  (2013)  Uric acid: A Key ingredient in the recipe of cardiorenal metabolic syndrome Cardiorenal Med 2013, 3; 208-220
  • Lishmanov A, Dorairajan S, Pak Y, Chaudhary Kunal, Chockalingam A (2013) Treatment of 25 OH Vitamin D in CKD stage 3 and 4 patients reduces the risk for cardiovascular events. Am J  Ther.  20(5): 480-486
  • Yerram Preethi and Chaudhary Kunal.  Calcific uremic arteriolopathy in end stage renal disease patients: pathophysiology and management” (2014) The Ochsner Journal: Vol. 14, No. 3, pp. 380-385
  • Chaudhary Kunal  , Harold Moore,  Ashish Tandon, Suneel Gupta, Ramesh Khanna , and Rajiv R. Mohan.  Nanotechnology and Adeno-associated virus based decorin gene therapy ameliorates  Peritoneal Fibrosis . (2014)   Am J Physiol- Renal Physiol 307 ( 7) F777-782. DOI: 10.1152/ajprenal.00653.2013
  • Rao Akhilesh, Pandya Vishwam, Chaudhary Kunal.   Lipid abnormalities  in kidney   disease and management strategies . (2015) World Journal of Nephrology  4(1): 83-91. DOI : 10.5527
  • Sivakumar Ardhanari, Kannuswamy Rohini , Chaudhary Kunal, Warren Lockette and Adam Whaley-Connell. Mineralocorticoid forms of secondary hypertension (2015) Advances in CKD (in press).